Company Delivers Significant Increases Across All Key Customer and Financial Metrics
Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, delivered strong business results in FY 2021, demonstrating rapid growth over the previous year. This positive performance was reflected in all important financial and operational measures for the company.
Read More: WISeKey Provides A Summary Of Its 2021 Key Business Milestones
“We are very pleased with the company’s rapid growth and strong business results in 2021. We finished the year with a lot of momentum and we look forward to carrying that energy into 2022,” explained Dave Gulezian, Co-Founder & CEO of Alucio.
Over this period, Alucio more than tripled the size of its customer base consisting of industry-leading life science organizations. The company now maintains a robust and diverse group of customers that range from small, pre-commercial biotechs to top-ten, global pharmaceutical manufacturers with extensive product portfolios.
Read More: SalesTechStar Interview With Jeremey Donovan, Head Of Revenue Strategy At Salesloft
Beyond the biopharma space, Alucio added major medical device customers in 2021 and also expanded beyond the company’s core focus in medical affairs into the market access area. The user count for the company’s flagship Beacon platform nearly quadrupled in 2021 as customers responded positively to the product’s content management features, HCP engagement capabilities and overall ease of use. Financially, all of these factors helped drive a substantial increase in annual recurring revenue (ARR) for the company of over 340% from the prior year.
“We are very pleased with the company’s rapid growth and strong business results in 2021. We finished the year with a lot of momentum and we look forward to carrying that energy into 2022,” explained Dave Gulezian, Co-Founder & CEO of Alucio. “All of our accomplishments as a company are truly driven by the talent, innovation and hard work of our dedicated team.”
